NO20011096D0 - Preventives or remedies for multiple organ failure - Google Patents

Preventives or remedies for multiple organ failure

Info

Publication number
NO20011096D0
NO20011096D0 NO20011096A NO20011096A NO20011096D0 NO 20011096 D0 NO20011096 D0 NO 20011096D0 NO 20011096 A NO20011096 A NO 20011096A NO 20011096 A NO20011096 A NO 20011096A NO 20011096 D0 NO20011096 D0 NO 20011096D0
Authority
NO
Norway
Prior art keywords
preventives
remedies
organ failure
multiple organ
failure
Prior art date
Application number
NO20011096A
Other languages
Norwegian (no)
Other versions
NO20011096L (en
Inventor
Tsuyoshi Hara
Kazuko Fujiwara
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20011096D0 publication Critical patent/NO20011096D0/en
Publication of NO20011096L publication Critical patent/NO20011096L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO20011096A 1998-09-03 2001-03-02 Preventives or remedies for multiple organ failure NO20011096L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10249492A JP2000080046A (en) 1998-09-03 1998-09-03 Prophylactic and/or therapeutic agent for multiple organ failure
PCT/JP1999/004783 WO2000013707A1 (en) 1998-09-03 1999-09-03 Preventives/remedies for multiple organ failure

Publications (2)

Publication Number Publication Date
NO20011096D0 true NO20011096D0 (en) 2001-03-02
NO20011096L NO20011096L (en) 2001-03-02

Family

ID=17193786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011096A NO20011096L (en) 1998-09-03 2001-03-02 Preventives or remedies for multiple organ failure

Country Status (12)

Country Link
US (1) US6596754B1 (en)
EP (1) EP1110556A4 (en)
JP (1) JP2000080046A (en)
KR (1) KR20010099628A (en)
CN (1) CN1315873A (en)
AU (1) AU5448699A (en)
CA (1) CA2342796A1 (en)
ID (1) ID28693A (en)
IL (1) IL141402A0 (en)
NO (1) NO20011096L (en)
TW (1) TW533074B (en)
WO (1) WO2000013707A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442143T1 (en) 2001-03-21 2009-09-15 Eisai R&D Man Co Ltd REDUCED DRUGS CONTAINING VITAMIN B2
CA2507026A1 (en) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited Imidazole derivatives, their production and use
PT1569912E (en) 2002-12-03 2015-09-15 Pharmacyclics Llc 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
TWI396686B (en) * 2004-05-21 2013-05-21 Takeda Pharmaceutical Cyclic amide derivative, and its production and use
ATE505192T1 (en) * 2005-06-09 2011-04-15 Bristol Myers Squibb Co PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PERSONS WITH MUTANT KIT PROTEIN
EP3525719B1 (en) 2016-10-12 2022-06-01 Solmetex LLC Dental amalgam separation and recycling system
CA3059529A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (en) 2017-04-14 2020-01-10 比利时胶囊公司 Pullulan polysaccharide capsule
US11679093B2 (en) 2018-06-11 2023-06-20 The Regents Of The University Of Colorado, A Body Corporate 2-naphthimidamides, analogues thereof, and methods of treatment using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466668A (en) * 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
IL101062A0 (en) * 1991-02-28 1992-11-15 Erba Carlo Spa Anti-thrombin polypeptides and their preparation
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JP3388803B2 (en) * 1993-05-20 2003-03-24 第一製薬株式会社 Method for producing optically active 7-amidinonaphthalene derivative

Also Published As

Publication number Publication date
JP2000080046A (en) 2000-03-21
CN1315873A (en) 2001-10-03
ID28693A (en) 2001-06-28
EP1110556A1 (en) 2001-06-27
EP1110556A4 (en) 2004-01-28
IL141402A0 (en) 2002-03-10
CA2342796A1 (en) 2000-03-16
KR20010099628A (en) 2001-11-09
WO2000013707A1 (en) 2000-03-16
US6596754B1 (en) 2003-07-22
NO20011096L (en) 2001-03-02
TW533074B (en) 2003-05-21
AU5448699A (en) 2000-03-27

Similar Documents

Publication Publication Date Title
DE69841198D1 (en) Adhesive composition for surgical purposes
ITMI991423A0 (en) PHOTOINITIATORS MADE OF O-ACILOXIME
DE69906420D1 (en) Applicable surgical marker applicator
DE59508511D1 (en) Latticework for orthopedic-traumatological surgery
DE69919555D1 (en) INSULATION SYSTEM FOR INSULATION PANEL OR THE LIKE
DE69906785D1 (en) MULTILAYER LINE
DE69714904D1 (en) Ventilation arrangement for buildings
FI980177A0 (en) Hydrofobisering system Foer papper eller motsvarande fiberprodukt
BR9706908A (en) Compositions for the treatment of renal failure comprising l-carnosine
NO20011096D0 (en) Preventives or remedies for multiple organ failure
ATE254214T1 (en) MULTI-LAYER TISSUE PAPER
ID23318A (en) ASSOCIATED LANSET LANING
EP1297839A4 (en) Preventives or remedies for heart failure
EA200000641A1 (en) MULTILAYER BOX
KR980000079U (en) Barn Emergency Ventilator
FI980867A0 (en) Stock Organs
NO993145D0 (en) Chocolate or composite coatings
FI980098A0 (en) Anordning i torkpartiet i en bestrykningsanordning, pappersmaskin eller motsvarande
DK1091875T3 (en) Pill-safe or pill-resistant close
NO20004825D0 (en) Aircraft operating system
FI980589A0 (en) Hoernkamin Foer anvaendning i en semesterstuga eller liknande
FI980279A0 (en) Bladkonstruktion Foer en innebandyklubba eller motsvarande
ES1040070Y (en) MODULAR COMPOSITION STRUCTURE FOR CEILINGS.
IT1306400B1 (en) PANEL FOR THE CONSTRUCTION OF WALLS AND RELATED CONSTRUCTION SYSTEM.
FI3928U1 (en) The stock joints for the log cabins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application